Рубрика
Blog
-
2023
-
i2020 Accelerator Invests in Developing Novel Highly-Specific Approaches to Treatment of Neurodegenerative Diseases Based on Previously Unrecognized Protein-Protein Interactions
-
New article «A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling»
-
Viriom Launches Reproductive Toxicity Studies for Elpida® (Elsulfavirine) Once Weekly Oral Formulation
-
ChemDiv, Inc. Opens the Unique Chemistry E-Commerce Store Offering the World’s Largest Small Molecule Inventory at STORE.CHEMDIV.COM
-
ChemDiv Created Unique KATO TM Platform for Development of Innovative Drugs Against Coronavirus Infection
-
Endo pays $658M in a further bet on collagen-based medicines, buying out longtime biopharma partner
-
Astellas Receives Positive CHMP Opinion for XTANDI™ (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer
-
ESTEVE and KOWA Pharmaceuticals America enter into an Exclusive License and Commercialization Agreement for rights to E-58425 for the potential management of acute pain in the United States
-
Methamphetamine use drove surge in heart failure hospitalizations, costs in California
-
Our covalent compound library is now available in a ready-to-dock format for BioSolveIT